Skip to content

Clinical trials

Cognitive Dysfunction trials in Brazil

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cognitive Dysfunction Country / region: Brazil Clear all

40 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20091
20101
20112
20121
20141
20152
20161
20173
20183
20193
20201
20215
20222
20231
20242
20255
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status14
Completed12
Recruiting6
Active, not recruiting4
Not yet recruiting2
Suspended1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Sao Paulo7
University of Sao Paulo General Hospital5
Hoffmann-La Roche3
Bristol-Myers Squibb2
Federal University of Rio Grande do Sul2
Hospital Israelita Albert Einstein2
Universidade Federal do Rio de Janeiro2
Centro Mente Aberta de Mindfulness1
Federal University of Paraíba1
Flavia orange1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cognitive Dysfunction40
Alzheimer Disease10
Dementia8
Stroke3
Bipolar Disorder2
COVID-192
Parkinson Disease2
Post-Acute COVID-19 Syndrome2
Anxiety Disorders1
Atrial Fibrillation1

Trials

Showing 26 to 40 of 40. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.